Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Endocrinology Stories

2013-09-12 16:26:45

Takeda and Arbor enter into a license, development and commercialization agreement for EDARBI (azilsartan medoxomil) and EDARBYCLOR (azilsartan medoxomil and chlorthalidone) in the U.S. DEERFIELD, Ill. and OSAKA, Japan and ATLANTA, Sept. 12, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and Arbor Pharmaceuticals Ireland Ltd., a wholly-owned subsidiary of Arbor Pharmaceuticals, LLC ("Arbor") announced today that Takeda and Arbor have entered into a license, development...

2013-09-12 08:25:37

NEW YORK, September 12, 2013 /PRNewswire/ -- Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of a new open access research publication - Journal of Clinical and Translational Endocrinology (JCTE). [http://www.jctejournal.com ] The scope of this new journal is patient-oriented research in a variety of disciplines in endocrinology, including diabetes,...

2013-09-10 23:26:56

Amy Medling, CHC, Certified Health Coach and founder of PCOS Diva.com, a website for women with Polycystic Ovarian Syndrome, will be presenting at the 2013 PCOS Foundation Symposium in Houston, TX. Houston, TX (PRWEB) September 10, 2013 In honor of National Polycystic Ovarian Syndrome (PCOS) Awareness Month, the PCOS Foundation is hosting the 2013 PCOS Foundation Symposium, a one day, free educational symposium that includes food, lectures, workshops and breakout sessions to learn more...

2013-09-10 04:22:07

LUND, Sweden, September 10, 2013 /PRNewswire/ -- Camurus announced today that Novartis has exercised its option to acquire an exclusive license for the further development and worldwide commercialization of CAM2029 for treatment of patients with acromegaly and neuroendocrine tumors (NETs). The license also covers additional future products based on the Camurus' FluidCrystal(R) Injection depot technology. (Logo:...

2013-09-09 12:27:14

First-in-Kind Alliance Sets Out to Break Taboo Around "Silent Symptom" of Menopause PLAINSBORO, N.J., Sept. 9, 2013 /PRNewswire/ -- As many as 75 percent of women who have gone through menopause are living with vaginal dryness, a bothersome symptom that they feel is negatively affecting their quality of life.([1,2]) Despite the high prevalence, only 25 percent of women with vaginal dryness will take action to resolve it.([1]) To address this, five leading women's health advocates today...

2013-09-04 12:33:42

Low testosterone and Low progesterone supplements change the course of two lives. More information available at www.testomeds.com BET SHEMESH, Israel, Sept. 4, 2013 /PRNewswire-iReach/ -- Pauline* and Marcus*'s marriage was in shambles, and they didn't know what to do. They thought back: they had met in the usual way (watching Love Actually at an airport bar during a Seattle-Pittsburg layover). Though the early days were difficult due to religious differences, they had worked...

2013-09-04 08:10:20

Breast cancer risk associated with use of hormone replacement therapy (HRT) among postmenopausal women was variable when analyzed by race/ethnicity, body mass index (BMI), and breast density, according to a new study published September 3 in the Journal of the National Cancer Institute. Studies have reported HRT use is associated with an increase in breast cancer risk. However, differential risks by BMI and breast density have been reported. Also, studies on the effect of HRT use on breast...

2013-09-03 23:21:42

Companies to Invest in New Facility, Increase Workforce Menlo Park, CA and Clearwater, FL (PRWEB) September 03, 2013 TesoRx Pharma, LLC and CoreRx, Inc. today announced a manufacturing joint venture to produce TSX-002, a first-in-class oral testosterone drug targeting the $2.5Billion low testosterone market. TesoRx’s novel, proprietary formulation orally delivers therapeutic levels of unmodified testosterone in a safe and convenient manner. The company will be commencing its final...

2013-08-30 08:24:53

IP Shakti, LLC is the exclusive broker of patents for therapeutic compounds currently in clinical development PRINCETON, N.J., Aug. 30, 2013 /PRNewswire/ -- IP Shakti has partnered with a California pharmaceutical company to market patent assets corresponding to three new therapeutics to treat women's health needs. This is a unique opportunity for large and small bio-medical research and development companies to access patent assets related to first-in-class therapeutic compounds...

2013-08-29 23:02:28

Glucose monitoring systems with an autocorrect feature that can detect red blood cells (hematocrit), vitamin C and other common interferents in burn patients’ blood are better for monitoring care, a pilot study conducted by UC Davis researchers at the School of Medicine and College of Engineering has found. Sacramento, CA (PRWEB) August 29, 2013 Glucose monitoring systems with an autocorrect feature that can detect red blood cells (hematocrit), vitamin C and other common interferents in...


Latest Endocrinology Reference Libraries

Osteoporosis International
2012-05-17 15:25:40

Osteoporosis International is a peer-reviewed medical journal published monthly by Springer Science+Business Media. It was established in 1990. It is the official journal of the International Osteoporosis Foundation and the National Osteoporosis Foundation. The journal includes original research on all areas of osteoporosis and related fields. It also publishes reviews, educational articles, and case reports. Editors-in-chief are R. Lindsay and J.A. Kanis. According to the Journal...

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

More Articles (2 articles) »